This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Jones J, Worobetz L, Bedi A, Manns B.A cost-utility analysis of infliximab compared with surgery for the treatment of ulcerative colitis: a public payer perspective. Digestive Disease Week 2009: 172 abstr. S1025, 30 May 2009. Available from: URL: http://www.ddw.org
Rights and permissions
About this article
Cite this article
Surgery wins over infliximab for UC ... just. Pharmacoecon. Outcomes News 582, 8 (2009). https://doi.org/10.2165/00151234-200905820-00019
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200905820-00019